Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (69)

Latest Posts

About This Stock More About This Stock
Stocks Are Heading Lower On September 10 Ahead Of The ECB
Article By: Michael J. Kramer
Thursday, September 10, 2020 7:16 AM EDT
Stocks are trading lower this morning ahead of the ECB rate announcement.
In this article: REGN, GILD, VRTX, SPY
E Market Briefing For Thursday, August 20
Article By: Gene Inger
Thursday, August 20, 2020 2:50 AM EDT
Health heaviness holds the Fed to a defensive stance while they express concern indirectly about systemic stability, and even higher yields 'pulling' policy shifts later in the course of developments; or sort of hinted-at by their oblique comments.
In this article: BA, SRNE, REGN, AAPL, GILD, INTC, NVDA, ORCL Also: VIX, SPX
5 Top-Ranked Stocks Driving ETF As S&P 500 Nears New Highs
Article By: Sweta Killa
Thursday, August 13, 2020 12:00 PM EDT
Though most stocks in the fund’s portfolio are in the green this year, here are five that are leading the way in the SPY ETF.
In this article: ROL, WST, REGN, CDNS, PYPL Also: SPY
Regeneron (REGN) Tops Q2 Earnings And Revenue Estimates
Article By: Zacks Investment Research
Wednesday, August 5, 2020 10:09 AM EDT
Regeneron came out with quarterly earnings of $7.16 per share.
In this article: REGN
REGN Flat Despite Covid-19 Antibody Drug Update
Article By: Schaeffers Research
Tuesday, August 4, 2020 11:00 AM EDT
The equity is up over 115% year-over-year.
In this article: REGN


Latest Tweets for $REGN

No tweets yet!


Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments